|
Bay Area Tumor Institute CCOP
|
2U10CA045461-18
|
$480,000
|
FEUSNER, JAMES
|
BAY AREA TUMOR INSTITUTE
|
|
Virginia Mason Community Clinical Oncology Program
|
3U10CA035192-24S1
|
$80,000
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-24
|
$391,000
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
DF/HCC Renal Cancer SPORE
|
5P50CA101942-05
|
$2,330,598
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
CCOP Research Base, PCPT/PCPT LTFU, and SELECT Programs
|
2U10CA037429-22
|
$14,335,283
|
Coltman, Charles
|
CANCER THERAPY AND RESEARCH CENTER
|
|
Hematopoietic Cell Transplantation for Hematologic Malignancies
|
3P01CA030206-25S1
|
$89,324
|
FORMAN, STEPHEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Hematopoietic Cell Transplantation for Hematologic Malignancies
|
5P01CA030206-25
|
$2,776,839
|
FORMAN, STEPHEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
City of Hope Lymphoma SPORE
|
5P50CA107399-04
|
$2,163,323
|
FORMAN, STEPHEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
City of Hope Southwest Oncology Group Clinical Trials
|
3U10CA046368-20S1
|
$32,200
|
MARGOLIN, KIM
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
City of Hope Southwest Oncology Group Clinical Trials
|
5U10CA046368-20
|
$326,504
|
MARGOLIN, KIM
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Antibody Targeted Radiation and Immunotherapy for the Treatment of Solid Tumors
|
2P01CA043904-16A1
|
$2,922,793
|
RAUBITSCHEK, ANDREW
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Therapeutic Studies of Primary CNS Malignancies-NABTT
|
5U01CA105706-04
|
$70,244
|
BARNETT, GENE
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Southwest Oncology Group
|
2U10CA004919-48
|
$192,303
|
BUDD, G
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Southwest Oncology Group
|
3U10CA004919-48S1
|
$25,000
|
BUDD, G
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Development Therapy for Metastatic Colorectal Cancer
|
7R01CA108929-03
|
$253,422
|
HOUGHTON, JANET
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Columbus Community Clinical Oncology Program
|
3U10CA035261-24S1
|
$120,000
|
KUEBLER, J
|
COLUMBUS COMMUNITY CLINICAL ONCOLOGY PRG
|
|
Columbus Community Clinical Oncology Program
|
5U10CA035261-24
|
$641,747
|
KUEBLER, J
|
COLUMBUS COMMUNITY CLINICAL ONCOLOGY PRG
|
|
Targeted Therapy of B-cell Malignancies
|
5P01CA103985-03
|
$1,603,282
|
GOLDENBERG, DAVID
|
CTR FOR MOLECULAR MEDICINE/IMMUNOLOGY
|
|
Bispecific Antibody Pretargeting for Therapy
|
5R01CA107088-02
|
$477,990
|
SHARKEY, ROBERT
|
CTR FOR MOLECULAR MEDICINE/IMMUNOLOGY
|
|
Bispecific Antibody Pretargeted Therapy of Pancreatic Cancer
|
5R01CA115755-02
|
$319,025
|
SHARKEY, ROBERT
|
CTR FOR MOLECULAR MEDICINE/IMMUNOLOGY
|
|
Dayton Clinical Oncology Program
|
5U10CA035090-25
|
$864,347
|
GROSS, HOWARD
|
DAYTON CLINICAL ONCOLOGY PROGRAM
|
|
Central Illinois Community Clinical Oncology Program
|
5U10CA045807-22
|
$1,067,633
|
WADE, JAMES
|
DECATUR MEMORIAL HOSPITAL
|
|
SPORE in Brain Cancer
|
3P50CA108786-04S1
|
$146,300
|
BIGNER, DARELL
|
DUKE UNIVERSITY
|
|
SPORE in Brain Cancer
|
5P50CA108786-04
|
$50,001
|
BIGNER, DARELL
|
DUKE UNIVERSITY
|
|
Expression Based Markers for Breast Cancer Detection
|
5U01CA084955-09
|
$269,369
|
Marks, Jeffrey
|
DUKE UNIVERSITY
|
|
MS4A Family Members in Health and Disease
|
5R01CA105001-04
|
$239,473
|
TEDDER, THOMAS
|
DUKE UNIVERSITY
|
|
Duluth Community Clinical Oncology Program
|
3U10CA035269-24S1
|
$80,000
|
Nikcevich, Daniel
|
DULUTH CLINIC, LTD.
|
|
Duluth Community Clinical Oncology Program
|
5U10CA035269-24
|
$587,154
|
Nikcevich, Daniel
|
DULUTH CLINIC, LTD.
|
|
EORTC DATA CENTER
|
5U10CA011488-37
|
$417,479
|
Sylvester, Richard
|
EUROPEAN ORG/RES/TREATMENT/CANCER
|
|
Analysis of Circulating Tumor Cells in a Phase I/II Study for Breast Cancer
|
5R21CA121541-02
|
$307,278
|
SWABY, RAMONA
|
FOX CHASE CANCER CENTER
|
|
Southwest Oncology Group Statistical Center
|
5U10CA038926-22
|
$4,612,382
|
CROWLEY, JOHN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
The Pacific Northwest Prostate Cancer SPORE
|
2P50CA097186-06
|
$2,360,341
|
NELSON, PETER
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Therapy of Lymphoma/Leukemia with Monoclonal Antibodies
|
5P01CA044991-20
|
$1,865,350
|
Press, Oliver
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Mixed Hematopoietic Chimerism after Stem Cell Allografts
|
5P01CA078902-09
|
$1,985,492
|
Storb, Rainer
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
PROSTATE, LUNG, COLORECTAL AND OVARIAN CANCER SCREENING TRIAL - SCREENING CENTERS
|
N01CN025522-086
|
$1,461,594
|
ISAACS, CLAUDINE
|
GEORGETOWN UNIVERSITY
|
|
PROSTATE, LUNG, COLORECTAL AND OVARIAN (PLCO) CANCER SCREENING TRIAL - SCREENING
|
N01CN025512-096
|
$2,501,456
|
KVALE, PAUL
|
HENRY FORD HEALTH SYSTEM
|
|
NEW APPLICATIONS IN BRAIN TUMOR THERAPY
|
5U01CA062432-13
|
$131,531
|
MIKKELSEN, TOM
|
HENRY FORD HEALTH SYSTEM
|
|
NEW APPROACHES TO BRAIN TUMOR THERAPY-(NABTT)
|
3U01CA062474-13S1
|
$32,164
|
BREM, HENRY
|
JOHNS HOPKINS UNIVERSITY
|
|
NEW APPROACHES TO BRAIN TUMOR THERAPY-(NABTT)
|
5U01CA062474-13
|
$116,242
|
BREM, HENRY
|
JOHNS HOPKINS UNIVERSITY
|
|
Experimental Therapy of Cancer by Costimulated Immunity
|
5R01CA085721-08
|
$325,256
|
Chen, Lieping
|
JOHNS HOPKINS UNIVERSITY
|
|
CD137 Antibody for Cancer Therapy
|
5R01CA106861-05
|
$317,808
|
Chen, Lieping
|
JOHNS HOPKINS UNIVERSITY
|
|
NABTT-Consortium Therapeutic Studies of CNS Malignancies
|
5U01CA062475-13
|
$586,490
|
GROSSMAN, STUART
|
JOHNS HOPKINS UNIVERSITY
|
|
Evaluation of BAY43-9006/Cetuximab in Colorectal Cancer
|
5R21CA117125-02
|
$282,586
|
MESSERSMITH, WELLS
|
JOHNS HOPKINS UNIVERSITY
|
|
Targeting Tumor Angiogenesis with SAHA and Bevacizumab in Kidney Cancer
|
1R21CA121590-01A2
|
$249,090
|
Pili, Roberto
|
JOHNS HOPKINS UNIVERSITY
|
|
Kansas City Clinical Oncology Program CCOP
|
5U10CA035176-24
|
$672,441
|
Gaur, Rakesh
|
KANSAS CITY CLINICAL ONCOLOGY PROGRAM
|
|
LSUHSC Minority Based Community Clinical Oncology
|
3U10CA063845-09S4
|
$332,201
|
VEITH, ROBERT
|
LOUISIANA STATE UNIV HSC NEW ORLEANS
|
|
LSUHSC-Shreveport Feist-Weiller Cancer Center MBCCOP
|
1U10CA128567-01
|
$322,000
|
MILLS, GLENN
|
LOUISIANA STATE UNIV HSC SHREVEPORT
|
|
Southwest Oncology Group
|
3U10CA046282-20S1
|
$43,000
|
STIFF, PATRICK
|
LOYOLA UNIVERSITY CHICAGO
|
|
Southwest Oncology Group
|
5U10CA046282-20
|
$425,510
|
STIFF, PATRICK
|
LOYOLA UNIVERSITY CHICAGO
|
|
PROSTATE, LUNG, COLORECTAL AND OVARIAN CANCER SCREENING TRIAL - SCREENING CENTERS
|
N01CN025518-083
|
$766,675
|
REDING, DOUGLAS
|
MARSHFIELD CLINIC
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|